Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction

The American Journal of Medicine(2020)10.1016/j.amjmed.2020.02.040Source: DataRank Database

Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction is a research paper published in The American Journal of Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 1.11)OA: greenTopics (66)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Milton Packer ORCID,Gauravpal S. Gill ORCID,Wen-Chih Wu,Wayne C. Levy ORCID,Michael R. Zile ORCID

Live enrichment

PubMed:32272101 PMC:PMC10463778 OpenAlex:https://openalex.org/W3014404577

National Heart, Lung, and Blood Institute

Grant: R01-HL085561-S

National Heart, Lung, and Blood Institute

Grant: R01-HL097047

NHLBI NIH HHS

Grant: R01 HL085561

HSRD VA

Grant: I01 HX001800

HSRD VA

Grant: I01 HX002422

NHLBI NIH HHS

Grant: R01 HL097047

GlaxoSmithKline

National Institutes of Health

FWCI

1.11

Citation Percentile

0.8%

Citation Trend

2020

2021

2022

2024

2025

greenLicense: https://www.elsevier.com/legal/tdmrep-license

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10463778/pdf/nihms-1582350.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0002934320302369?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0002934320302369?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10463778

Fields of Study

Heart Failure Treatment and ManagementAtrial Fibrillation Management and OutcomesCardiac Arrest and ResuscitationAdrenergic beta-AntagonistsAgedAged, 80 and overAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsAnti-Arrhythmia AgentsAnticoagulantsAtrial FibrillationCardiotonic AgentsCause of DeathDigoxinFemaleHeart FailureHospitalizationHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMineralocorticoid Receptor AntagonistsMortalityPatient ReadmissionPlatelet Aggregation InhibitorsPropensity ScoreProportional Hazards ModelsRegistriesSodium Potassium Chloride Symporter InhibitorsStroke VolumeWarfarin

MeSH Terms

Adrenergic beta-AntagonistsAgedAged, 80 and overMineralocorticoid Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsAnti-Arrhythmia AgentsAnticoagulantsAtrial FibrillationCardiotonic AgentsCause of DeathDigoxinFemaleHeart FailureHospitalizationHumansMaleMortalityPatient ReadmissionPlatelet Aggregation InhibitorsRegistriesStroke VolumeWarfarinProportional Hazards ModelsHydroxymethylglutaryl-CoA Reductase InhibitorsSodium Potassium Chloride Symporter InhibitorsPropensity ScoreAngiotensin Receptor Antagonists

Keywords

MedicineDigoxinEjection fractionHeart failureCardiologyInternal medicineMortalityReadmissionHeart Failure With Preserved Ejection Fraction

Sustainable Development Goals

SDG 0: Good health and well-being